<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en-US"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Sample Size and Non-Inferiority Margin for Vaccine Efficacy Trials — ss_ni_ve • ssutil</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Sample Size and Non-Inferiority Margin for Vaccine Efficacy Trials — ss_ni_ve"><meta name="description" content="Computes the non-inferiority margin, number of events, and maximum hazard ratio (HR)
to declare non-inferiority in vaccine efficacy (VE) trials, based on the approach
described by Fleming et al. (2021)."><meta property="og:description" content="Computes the non-inferiority margin, number of events, and maximum hazard ratio (HR)
to declare non-inferiority in vaccine efficacy (VE) trials, based on the approach
described by Fleming et al. (2021)."><meta property="og:image" content="https://johnaponte.github.io/ssutil/logo.png"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">ssutil</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.0</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/equivalence.html">Equivalence Testing for Normal Outcomes</a></li>
    <li><a class="dropdown-item" href="../articles/iz_binomial.html">Selecting the best group using the Indifferent-Zone approach for binomial outcomes</a></li>
    <li><a class="dropdown-item" href="../articles/iz_normal.html">Selecting the best group using the Indifferent-Zone approach for normal outcomes</a></li>
    <li><a class="dropdown-item" href="../articles/negative_binomial.html">Simulations for Negative Binomial outcomes</a></li>
    <li><a class="dropdown-item" href="../articles/non_inferiority.html">Simulations for Non-inferiority trials</a></li>
    <li><a class="dropdown-item" href="../articles/power_single_rate.html">Detectable Event Rate for Safety Signal Detection: Using `power_single_rate`</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Sample Size and Non-Inferiority Margin for Vaccine Efficacy Trials</h1>

      <div class="d-none name"><code>ss_ni_ve.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Computes the non-inferiority margin, number of events, and maximum hazard ratio (HR)
to declare non-inferiority in vaccine efficacy (VE) trials, based on the approach
described by Fleming et al. (2021).</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">ss_ni_ve</span><span class="op">(</span><span class="va">ve_lci</span>, alpha <span class="op">=</span> <span class="fl">0.025</span>, power <span class="op">=</span> <span class="fl">0.9</span>, use70 <span class="op">=</span> <span class="cn">FALSE</span>, preserve <span class="op">=</span> <span class="fl">0.5</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-ve-lci">ve_lci<a class="anchor" aria-label="anchor" href="#arg-ve-lci"></a></dt>
<dd><p>Numeric. Lower bound of the current vaccine's efficacy (e.g., 0.95 for 95% VE).</p></dd>


<dt id="arg-alpha">alpha<a class="anchor" aria-label="anchor" href="#arg-alpha"></a></dt>
<dd><p>Numeric. Type I error rate (default = 0.025).</p></dd>


<dt id="arg-power">power<a class="anchor" aria-label="anchor" href="#arg-power"></a></dt>
<dd><p>Numeric. Desired power for the test (default = 0.90).</p></dd>


<dt id="arg-use-">use70<a class="anchor" aria-label="anchor" href="#arg-use-"></a></dt>
<dd><p>Logical. If <code>TRUE</code>, assumes at least 30% VE for the new vaccine (the 90–70 rule); otherwise, preserves a fixed fraction of the reference VE.</p></dd>


<dt id="arg-preserve">preserve<a class="anchor" aria-label="anchor" href="#arg-preserve"></a></dt>
<dd><p>Numeric. Proportion of the current vaccine's efficacy to preserve under <code>use70 = FALSE</code> (default = 0.5).</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>A named list with:</p><ul><li><p>Upper limit of the HR used to estimate the sample size: Hazard ratio corresponding to <code>ve_lci</code>.</p></li>
<li><p>Non-inferior margin in HR scale: Non-inferiority margin expressed as a hazard ratio.</p></li>
<li><p>Alpha: The type I error used.</p></li>
<li><p>Power: The power used.</p></li>
<li><p>Total number of events: Total number of events required in the trial.</p></li>
<li><p>Max HR to declare NI: Maximum observed hazard ratio that satisfies the non-inferiority criterion.</p></li>
<li><p>Max number of events in the experimental group: Maximum number of events in the experimental group still compatible with non-inferiority.</p></li>
<li><p>Non-inferior criteria: Description of the applied non-inferiority rule ("At least 30% VE" or "or preserved effect").</p></li>
</ul></div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>The method applies either the 95–95 rule or 90–70 rule, depending on whether a minimum
VE of 30% is assumed (<code>use70 = TRUE</code>) or 50% of the current VE is preserved.</p>
<p>This implementation approximates Table 1 of the paper using exact binomial confidence intervals
via <code>binom.test</code> and the <code>nBinomial1Sample</code> function from <span class="pkg">gsDesign</span>.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Fleming, T.R., Powers, J.H., &amp; Huang, Y. (2021).
The use of active controls and non-inferiority studies in evaluating COVID-19 vaccines.
<em>Clinical Trials</em>, 18(3), 335–342. <a href="https://doi.org/10.1177/1740774520988244" class="external-link">doi:10.1177/1740774520988244</a></p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu">ss_ni_ve</span><span class="op">(</span>ve_lci <span class="op">=</span> <span class="fl">0.95</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $`Upper limit of the HR used to estimate the sample size`</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 0.05</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $`Non-inferior margin in HR scale`</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 4.472136</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $Alpha</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 0.025</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $Power</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 0.9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $`Total number of events`</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 28</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $`Max HR to declare NI`</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 1.8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $`Max number of events in the experimental group`</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 18</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $`Non-inferior criteria`</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "Preserve at least 50% of the VE in the new vaccine"</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by John J. Aponte.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

